These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11850848)

  • 1. p21B, a variant of p21(Waf1/Cip1), is induced by the p53 family.
    Nozell S; Chen X
    Oncogene; 2002 Feb; 21(8):1285-94. PubMed ID: 11850848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two new p73 splice variants, gamma and delta, with different transcriptional activity.
    De Laurenzi V; Costanzo A; Barcaroli D; Terrinoni A; Falco M; Annicchiarico-Petruzzelli M; Levrero M; Melino G
    J Exp Med; 1998 Nov; 188(9):1763-8. PubMed ID: 9802988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line.
    Matsui TA; Sowa Y; Murata H; Takagi K; Nakanishi R; Aoki S; Yoshikawa M; Kobayashi M; Sakabe T; Kubo T; Sakai T
    Int J Oncol; 2007 Oct; 31(4):915-22. PubMed ID: 17786325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J; Le HV; Massagué J
    Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T-cell leukemia virus type 1 Tax activates cyclin-dependent kinase inhibitor p21/Waf1/Cip1 expression through a p53-independent mechanism: Inhibition of cdk2.
    Chowdhury IH; Farhadi A; Wang XF; Robb ML; Birx DL; Kim JH
    Int J Cancer; 2003 Nov; 107(4):603-11. PubMed ID: 14520699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cells.
    Wu Q; Kirschmeier P; Hockenberry T; Yang TY; Brassard DL; Wang L; McClanahan T; Black S; Rizzi G; Musco ML; Mirza A; Liu S
    J Biol Chem; 2002 Sep; 277(39):36329-37. PubMed ID: 12138103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the p53 homolog p73 by adenoviral oncogene E1A.
    Das S; El-Deiry WS; Somasundaram K
    J Biol Chem; 2003 May; 278(20):18313-20. PubMed ID: 12639967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and epigenetic changes in p21 and p21B do not correlate with resistance to doxorubicin or mitomycin and 5-fluorouracil in locally advanced breast cancer.
    Staalesen V; Leirvaag B; Lillehaug JR; Lønning PE
    Clin Cancer Res; 2004 May; 10(10):3438-43. PubMed ID: 15161699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
    Kralj M; Husnjak K; Körbler T; Pavelić J
    Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p21(WAF1/CIP1) promoter is methylated in Rat-1 cells: stable restoration of p53-dependent p21(WAF1/CIP1) expression after transfection of a genomic clone containing the p21(WAF1/CIP1) gene.
    Allan LA; Duhig T; Read M; Fried M
    Mol Cell Biol; 2000 Feb; 20(4):1291-8. PubMed ID: 10648615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p21/CDKN1A mediates negative regulation of transcription by p53.
    Löhr K; Möritz C; Contente A; Dobbelstein M
    J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple alternate p21 transcripts are regulated by p53 in human cells.
    Radhakrishnan SK; Gierut J; Gartel AL
    Oncogene; 2006 Mar; 25(12):1812-5. PubMed ID: 16261158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-barr virus nuclear antigen 2 retards cell growth, induces p21(WAF1) expression, and modulates p53 activity post-translationally.
    Lin CS; Kuo HH; Chen JY; Yang CS; Wang WB
    J Mol Biol; 2000 Oct; 303(1):7-23. PubMed ID: 11021966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged progestin treatment induces the promoter of CDK inhibitor p21 Cip1,Waf1 through activation of p53 in human breast and endometrial tumor cells.
    Kester HA; Sonneveld E; van der Saag PT; van der Burg B
    Exp Cell Res; 2003 Apr; 284(2):264-73. PubMed ID: 12651158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ING1b decreases cell proliferation through p53-dependent and -independent mechanisms.
    Tsang FC; Po LS; Leung KM; Lau A; Siu WY; Poon RY
    FEBS Lett; 2003 Oct; 553(3):277-85. PubMed ID: 14572637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
    Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
    Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain.
    Roth J; Koch P; Contente A; Dobbelstein M
    Oncogene; 2000 Mar; 19(14):1834-42. PubMed ID: 10777217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional repression of p21(waf1) promoter by hepatitis B virus X protein via a p53-independent pathway.
    Ahn JY; Chung EY; Kwun HJ; Jang KL
    Gene; 2001 Sep; 275(1):163-8. PubMed ID: 11574165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.